Search Results - "NORMAN, Philip S"

Immunotherapy: 1999-2004 by Norman, Philip S.

“…Allergen immunotherapy continues to be used worldwide in the management of allergic rhinitis and asthma. We continue to refine our knowledge of the indications…”
Get full text

Outcomes of Allergy to Insect Stings in Children, with and without Venom Immunotherapy by Golden, David B.K, Kagey-Sobotka, Anne, Norman, Philip S, Hamilton, Robert G, Lichtenstein, Lawrence M

“…About 1 out of 100 children who are stung by an insect from the order Hymenoptera has a systemic allergic reaction. Although it has been suggested that…”
Get full text

Allergen-specific immunotherapy by Nelson, Harold S, Norman, Philip S

“…Specific immunotherapy was introduced for the treatment of grass pollen-induced hay fever in 1911. The treatment was soon extended to other pollens as well as…”
Get more information

Insect sting allergy with negative venom skin test responses by GOLDEN, David B. K, KAGEY-SOBOTKA, Anne, NORMAN, Philip S, HAMILTON, Robert G, LICHTENSTEIN, Lawrence M

“…In our 1976 controlled venom immuno rapy trial, 33% of 182 patients with a history of systemic reactions to insect stings were excluded because of negative…”
Get full text

Sublingual swallow immunotherapy in the new world by Norman, Philip S

Get more information

Ragweed Immunotherapy in Adult Asthma by Creticos, Peter S, Reed, Charles E, Norman, Philip S, Khoury, Jane, Adkinson, N. Franklin, Buncher, C. Ralph, Busse, William W, Bush, Robert K, Gadde, Jyothi, Li, James T, Richerson, Hal B, Rosenthal, Richard R, Solomon, William R, Steinberg, Paul, Yunginger, John W

“…The efficacy of allergen immunotherapy in allergic rhinitis has been repeatedly demonstrated, and the technique is widely used. 1,2 Immunotherapy in allergic…”
Get full text

Introduction: Purpose and format of the conference by Norman, Philip S.

“…[...]of these uncertainties, standards for prevention of latex allergies or the medical treatment of the individual suspected of having latex allergies are…”
Get full text

Inflammatory mediators in late antigen-induced rhinitis by Naclerio, R M, Proud, D, Togias, A G, Adkinson, Jr, N F, Meyers, D A, Kagey-Sobotka, A, Plaut, M, Norman, P S, Lichtenstein, L M

“…To investigate the mechanisms responsible for the late-phase response in patients with allergies, we measured four biochemical mediators (histamine,…”
Get more information

Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids by Pipkorn, U, Proud, D, Lichtenstein, L M, Kagey-Sobotka, A, Norman, P S, Naclerio, R M

“…Patients with allergic rhinitis often have immediate symptoms after antigen challenge (the early-phase response), followed several hours later by a recurrence…”
Get more information

Memorial. Thomas E. Van Metre, Jr. 1923-1996 by Norman, Philip S, Adkinson, Jr, N Franklin

Get full text

Peptide leukotriene release after antigen challenge in patients sensitive to ragweed by Creticos, P S, Peters, S P, Adkinson, Jr, N F, Naclerio, R M, Hayes, E C, Norman, P S, Lichtenstein, L M

“…Slow-reacting substance of anaphylaxis (composed of leukotrienes C, D, and E) is released in vitro by the interaction of antigen and IgE antibody on human mast…”
Get more information

Clinical and immunologic effects of component peptides in Allervax Cat by Norman, P S, Nicodemus, C F, Creticos, P S, Wood, R A, Eggleston, P A, Lichtenstein, L M, Kagey-Sobotka, A, Proud, D

“…Peptides have been designed to be T cell tolerogenic for the principal allergens of the cat. These have been administered in several dosage programs to…”
Get more information

Responses to ragweed-pollen nasal challenge before and after immunotherapy by Creticos, P S, Marsh, D G, Proud, D, Kagey-Sobotka, A, Adkinson, Jr, N F, Friedhoff, L, Naclerio, R M, Lichtenstein, L M, Norman, P S

“…To evaluate whether immunotherapy reduces mediator release after nasal challenge, we followed previously untreated patients with ragweed hay fever through 2…”
Get more information

Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper by Bousquet, Jean, Lockey, Richard, Malling, Hans-Jorgen

“…The World Health Organization and various allergy, asthma, and immunology societies throughout the world met on January 27 through 29, 1997, in Geneva,…”
Get full text

Clinical aspects of allergic disease: A double-blind study of the discontinuation of ragweed immunotherapy by Naclerio, Robert M., Proud, David, Moylan, Birgitta, Balcer, Susan, Freidhoff, Linda, Kagey-Sobotka, Anne, Lichtenstein, Lawrence M., Creticos, Peter S., Hamilton, Robert G., Norman, Philip S.

“…Background: Immunotherapy effectively treats the symptoms of allergic rhinitis and improves its pathophysiology. We studied whether the effects of…”
Get full text

Acute severe urticaria and angioedema leading to myocardial infarction by Vaswani, S K, Plack, R H, Norman, P S

Get more information

Immunotherapy With Allergens by Creticos, Peter S, Norman, Philip S

“…IMMUNOTHERAPY is the art of administering increasing doses of a specific extract comprising allergens to which the sensitive (atopic) individual would respond…”
Get full text

Dose response of IgE and IgG antibodies during ragweed immunotherapy by Creticos, P S, Van Metre, T E, Mardiney, M R, Rosenberg, G L, Norman, P S, Adkinson, Jr, N F

“…We studied the detailed dose-response relationship for ragweed (RW) antibody responses in 51 patients who received maximal-dose immunotherapy with crude RW…”
Get more information

Demonstration of Inhibition of Mediator Release From Human Mast Cells by Azatadine Base: In Vivo and In Vitro Evaluation by Togias, Alkis G, Naclerio, Robert M, Warner, Jane, Proud, David, Kagey-Sobotka, Anne, Nimmagadda, Indira, Norman, Philip S, Lichtenstein, Lawrence M

“…In vitro experimentation using dispersed human lung mast cells demonstrated that azatadine base, a compound with known H1-antihistamine properties, inhibited…”
Get full text

Studies on allergoids from naturally occurring allergens. III. Preparation of ragweed pollen allergoids by aldehyde modification in two steps by Marsh, D G, Norman, P S, Roebber, M, Lichtenstein, L M

“…We have devised a new process for modifying heat-labile allergens, which employs a sequential "two-step" incubation at temperatures of 10 degree C and 30…”
Get more information